Researchers conducted a prospective population-based analysis to understand whether vitamin D levels were associated with cardiovascular disease events and mortality, and overall mortality.
By Dr. Chinta SidharthanSep 20 2023Reviewed by Sophia Coveney In a recent study published in the journal Nutrients, researchers conducted a prospective population-based analysis to understand whether vitamin D levels were associated with cardiovascular disease events and mortality, and overall mortality.
The numerous differences and limitations in previous studies regarding vitamin D dosing, participant diversity, variations in the genes involved in vitamin D metabolism, and insufficient follow-up durations have also presented challenges in elucidating the link between vitamin D levels and cardiovascular disease risk.
Related StoriesThe participants were required to fill out questionnaires, provide blood samples for various measurements, and undergo a clinical examination. The study was conducted over three-year periods starting in 2003, with the third follow-up ending in 2021. Other biological measurements, such as total and high-density lipoprotein cholesterol levels and blood glucose levels, were also obtained from the freshly collected blood samples.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers find new mechanisms that cause blindness and open the door to new treatmentsThere are still many enigmas about the mechanism of action of the CERKL gene, which causes retinitis pigmentosa and other hereditary vision diseases. Now, a team from the University of Barcelona has described how the lack of the CERKL gene alters the ability of retinal cells to fight oxidative stress generated by light and triggers cell death mechanisms that cause blindness.
Read more »
Cancer surgery survivor helping researchers in new studySharon Applin had all the organs in her pelvis removed and wants her experience to aid other patients.
Read more »
Researchers discover possible new treatment for triple-negative breast cancerZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer. Schug's paper, titled 'Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer,' demonstrates a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. Schug's research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.
Read more »
Researchers identify new blood marker for dopamine system damageThe marker in question is called DOPA decarboxylase (DCC). In the current study, DCC was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency in the brain. However, the marker was normal in other brain diseases such as Alzheimer's disease. The researchers even noticed that DCC was elevated in individuals with Parkinson's many years before they developed any symptoms.
Read more »
Gaining new insights into neurological diseases by studying circular RNAs in brain cellsResearchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells.
Read more »